We distribute our research widely to institutional and retail investors through various channels, including our proprietary database, website, and other platforms (such as Bloomberg, Thomson Reuters and Factset).

We are fully MiFID II compliant. Our research is paid for by our corporate clients, and we do not carry out any execution business.

Published reports can be obtained by searching our Research Library below, or directly from the relevant Company Pages.

Advanced search
Date range (dd-mm-yyyy)


The defining inflection point expected within three weeks

Update | 17 August 2018


First NBT system delivered in US for Major Depression indication

Lighthouse | 16 August 2018


Transitioning with growing confidence

Update | 30 July 2018

Tissue Regenix

Creating the right conditions for future growth

Initiation | 23 July 2018


Good CARMA: IND milestone achieved

Update | 16 July 2018


Entering the next stimulating phase

Initiation | 02 July 2018


Biomarkers point the way ahead

Update | 27 June 2018


Phase II NSCLC combination study to advance into second stage

Lighthouse | 26 June 2018


Growing US CERAMENT BVF in-market sales

Lighthouse | 21 June 2018


Second CRADA with the NIH to advance CRISPR therapies

Lighthouse | 11 June 2018
1 2 3 4 5 6 7 8 9 10 11
105 results found.